1. Home
  2. OVID vs MGLD Comparison

OVID vs MGLD Comparison

Compare OVID & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • MGLD
  • Stock Information
  • Founded
  • OVID 2014
  • MGLD 1996
  • Country
  • OVID United States
  • MGLD United States
  • Employees
  • OVID N/A
  • MGLD N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • MGLD Finance/Investors Services
  • Sector
  • OVID Health Care
  • MGLD Finance
  • Exchange
  • OVID Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • OVID 47.1M
  • MGLD 45.4M
  • IPO Year
  • OVID 2017
  • MGLD N/A
  • Fundamental
  • Price
  • OVID $0.62
  • MGLD $0.97
  • Analyst Decision
  • OVID Strong Buy
  • MGLD
  • Analyst Count
  • OVID 6
  • MGLD 0
  • Target Price
  • OVID $4.03
  • MGLD N/A
  • AVG Volume (30 Days)
  • OVID 467.5K
  • MGLD 68.0K
  • Earning Date
  • OVID 03-07-2025
  • MGLD 03-04-2025
  • Dividend Yield
  • OVID N/A
  • MGLD N/A
  • EPS Growth
  • OVID N/A
  • MGLD N/A
  • EPS
  • OVID N/A
  • MGLD N/A
  • Revenue
  • OVID $631,695.00
  • MGLD $32,057,000.00
  • Revenue This Year
  • OVID $71.38
  • MGLD N/A
  • Revenue Next Year
  • OVID N/A
  • MGLD N/A
  • P/E Ratio
  • OVID N/A
  • MGLD N/A
  • Revenue Growth
  • OVID 113.21
  • MGLD N/A
  • 52 Week Low
  • OVID $0.56
  • MGLD $0.95
  • 52 Week High
  • OVID $3.79
  • MGLD $2.10
  • Technical
  • Relative Strength Index (RSI)
  • OVID 38.62
  • MGLD 33.18
  • Support Level
  • OVID $0.56
  • MGLD $1.00
  • Resistance Level
  • OVID $0.67
  • MGLD $1.16
  • Average True Range (ATR)
  • OVID 0.06
  • MGLD 0.07
  • MACD
  • OVID 0.00
  • MGLD 0.01
  • Stochastic Oscillator
  • OVID 35.94
  • MGLD 0.37

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: